background
advanc
made
select
sensit
cell
line
isol
earli
detect
respiratori
viru
growth
cell
rapid
cultur
assay
product
monoclon
antibodi
improv
mani
test
immunofluoresc
detect
viru
antigen
nasopharyng
aspir
highli
sensit
antigen
detect
timeresolv
fluoroimmunoassay
trfia
biotinenzym
immunoassay
bioth
final
polymeras
chain
reaction
pcr
detect
respiratori
viru
dna
rna
clinic
specimen
advanc
contribut
new
improv
possibl
diagnosi
respiratori
viru
infect
object
studi
design
review
summar
experi
last
year
develop
diagnost
test
respiratori
viru
infect
use
test
daili
diagnost
work
epidemiolog
studi
result
immunofluoresc
test
base
monoclon
antibodi
allmonoclon
trfia
biotinenzym
immunoassay
eia
sensit
specif
compar
well
sensit
viru
cultur
pcr
follow
liquidphas
hybrid
sensit
method
detect
adenoviru
dna
enteroviru
rhinoviru
rna
clinic
specimen
igg
eia
pair
acut
convalesc
phase
sera
sensit
serolog
test
respiratori
viru
infect
valuabl
refer
method
evalu
sensit
new
diagnost
test
igg
avid
test
distinguish
primari
infect
reinfect
least
respiratori
syncyti
viru
rsv
infect
igm
antibodi
assay
hand
low
sensit
studi
conclus
choic
diagnost
method
respiratori
viru
infect
depend
type
locat
laboratori
number
specimen
test
previou
experi
laboratori
viru
cultur
whenev
possibl
basic
diagnost
method
result
includ
identif
viru
avail
h
later
result
rapid
diagnost
test
small
laboratori
especi
hospit
specimen
transport
well
organ
immunofluoresc
may
best
choic
antigen
detect
provis
experienc
microscopist
good
uv
microscop
avail
laboratori
receiv
larg
number
specimen
previou
experi
eia
biotineia
trfia
may
practic
techniqu
advantag
includ
stabil
antigen
clinic
sampl
sinc
intact
exfoli
epitheli
cell
requir
treatment
specimen
practic
test
larg
number
specimen
possibl
read
print
test
result
less
subject
read
fluoresc
microscopi
larger
role
pcr
diagnosi
respiratori
viru
infect
depend
futur
develop
practic
method
extract
dna
rna
purifi
extract
nonspecif
inhibitor
plu
improv
minim
crosscontamin
gener
new
develop
respiratori
viru
diagnosi
follow
trend
viral
diagnosi
rapid
diagnost
method
particular
import
respiratori
virus
sinc
short
incub
period
epidem
spread
quickli
even
global
improv
respiratori
viru
diagnost
method
includ
introduct
sensit
cell
line
viru
cultur
earli
detect
viral
antigen
cultur
immunoperoxidas
stain
ip
monoclon
antibodi
rapid
cultur
assay
applic
monoclon
antibodi
immunofluoresc
enzym
immunoassay
eia
timeresolv
fluoroimmunoassay
trfia
detect
viral
antigen
directli
clinic
specimen
polymeras
chain
reaction
pcr
detect
viral
dna
rna
clinic
specimen
follow
demonstr
specif
pcr
product
liquidphas
hybrid
review
focus
experi
develop
diagnost
method
respiratori
virus
particularli
newer
trend
convent
techniqu
briefli
discuss
excel
specimen
viru
cultur
antigen
detect
pcr
nasopharyng
aspir
npa
collect
dispos
mucu
extractor
wari
et
al
viru
cultur
cotton
stick
dip
freshli
collect
aspir
specimen
place
viral
transport
medium
specimen
viru
isol
immunofluoresc
assay
ifa
must
kept
refriger
process
laboratori
specimen
viru
isol
process
within
h
storag
consid
antigen
assay
trfia
biotineia
transport
storag
specimen
less
critic
specimen
commonli
use
diagnosi
respiratori
viru
infect
nasal
wash
well
throat
andor
nasal
swab
clinic
indic
bronchoalveolar
lavag
transtrach
aspir
consid
pcr
specimen
use
minim
amount
viru
requir
hierholz
et
al
detail
specimen
collect
provid
elsewher
hierholz
johnson
lennett
et
al
schmidt
emmon
process
viral
isol
specimen
treat
antibiot
mix
well
clarifi
lowspe
centrifug
inocul
onto
cell
cultur
monolay
cultur
includ
continu
human
epitheli
line
hela
human
embryon
lung
diploid
fibroblast
cell
strain
hlf
helf
human
lung
mucoepidermoid
cell
replac
primari
rhesu
monkey
kidney
rmk
cell
applic
castel
et
al
hierholz
et
al
human
rhabdomyosarcoma
cell
rd
broad
practic
coverag
virus
hierholz
hierholz
hatch
inoculum
adsorb
monolay
ambient
temperatur
cultur
fed
mainten
medium
incub
sever
week
subpassag
requir
tube
cultur
mk
agmk
monkey
kidney
cell
deriv
line
vero
etc
diploid
fibroblast
cell
cultur
cell
roll
roller
drum
agit
rocker
platform
cultur
hek
kb
hela
need
roll
except
measl
viru
isol
hek
respiratori
syncyti
viru
rsv
isol
viral
growth
detect
cytopath
effect
cpe
light
microscopi
hemadsorpt
ha
herp
simplex
grow
well
mani
cell
type
notabl
primari
rabbit
kidney
hek
hela
hlf
mink
lung
cell
type
usual
genit
isol
grow
slowli
type
cytomegaloviru
cmv
notabl
labil
viru
herpesviru
shed
great
amount
urin
replic
slowli
roller
cultur
diploid
fibroblast
cell
produc
giant
cell
day
herpesvirus
readili
visual
em
cubic
icosahedr
shape
capsid
promin
palmer
martin
virus
commonli
identifi
ifa
eia
ip
dna
probe
pcr
adenovirus
replic
readili
hek
cell
without
roll
among
easier
virus
identifi
produc
excess
quantiti
solubl
antigen
adenovirus
differenti
virus
may
grow
cell
similar
cpe
em
complement
fixat
cf
latex
agglutin
la
ifa
eia
trfia
dna
probe
restrict
enzym
pcr
suitabl
primer
cytolog
method
serotyp
hemagglutinationinhibit
serum
neutral
test
parainfluenza
mump
virus
replic
well
roller
cultur
cell
fortifi
medium
contain
trypsin
mk
cell
without
trypsin
castel
et
al
cpe
induc
virus
may
develop
day
cultur
blindpassag
held
addit
week
ensur
viral
growth
cell
rare
becom
detach
may
show
obviou
cpe
mk
cultur
virus
must
hemadsorb
guinea
pig
human
monkey
erythrocyt
end
cultur
period
virus
type
hemagglutin
inhibit
hi
ifa
eia
trfia
test
measl
viru
caus
cpe
agmk
vero
hek
cell
day
roller
cultur
cpe
usual
develop
slowli
may
recogn
result
monolay
hemadsorb
vervet
monkey
erythrocyt
viru
identifi
hi
test
vervet
erythrocyt
ifa
eia
neutral
test
hybrid
pcr
test
rsv
produc
distinct
syncytia
hela
cell
day
roller
cultur
group
b
strain
rsv
readili
identifi
ifa
eia
trfia
test
anderson
et
al
hierholz
et
al
hierholz
et
al
lennett
et
al
wari
influenza
b
c
virus
best
recov
roller
cultur
mk
mdck
cell
embryon
egg
chick
embryo
mdck
cell
requir
fortifi
medium
contain
trypsin
optim
sensit
frank
et
al
klenk
et
al
meguro
et
al
virus
detect
mk
cell
hemadsorpt
mdck
cell
ha
identifi
ifa
ipa
eia
hi
neutral
test
grandien
et
al
ziegler
et
al
enterovirus
rhinovirus
produc
cpe
mk
hela
rd
trypsin
treat
diploid
fibroblast
cell
prefer
roller
cultur
coxsacki
virus
grow
suckl
mous
brain
enterovirus
distinguish
rhinovirus
former
acid
stabil
virus
serotyp
neutral
test
agbalika
et
al
hierholz
hatch
hyypii
stanway
lennett
et
al
coronavirus
best
identifi
directli
nasal
throat
specimen
fa
eia
trfia
virus
extrem
labil
difficult
recov
laboratori
peplom
constitut
primari
antigen
detect
test
includ
hi
test
strain
hierholz
et
al
rapid
cultur
assay
combin
high
sensit
standard
viru
isol
speed
cell
cultur
independ
method
detect
viral
antigen
nucleic
acid
clinic
specimen
viral
antigen
detect
cell
cultur
immunolog
stain
h
inocul
usual
distinct
viru
induc
cpe
microscop
visibl
cell
grown
shell
vial
cell
cultur
dish
clinic
specimen
inocul
adequ
number
vial
well
cultur
centrifug
approxim
x
g
ambient
temperatur
rain
document
centrifug
inocul
increas
sensit
rapid
cultur
assay
number
virus
thereaft
cultur
incub
atmospher
appropri
period
next
cultur
medium
remov
cell
wash
phosphatebuff
salin
pb
fix
aceton
methanol
cell
grown
plastic
dish
aceton
use
concentr
pb
undilut
aceton
melt
plastic
viral
antigen
cultur
cell
detect
ifa
ipa
ifa
cultur
usual
grown
coverslip
shell
vial
stain
coverslip
mount
microscop
slide
ipa
stain
perform
plate
read
x
x
magnif
invert
microscop
optim
condit
viral
plaqu
grow
larg
enough
overnight
incub
identifi
nake
eye
stain
ziegler
et
al
ziegler
et
al
theoret
sensit
rapid
cultur
assay
one
infecti
viru
per
inocul
volum
rapid
cultur
assay
first
found
wide
applic
detect
cmv
induc
earli
nuclear
antigen
infect
human
diploid
fibroblast
cell
gleav
et
al
griffith
et
al
identif
subtyp
herp
simplex
virus
hsv
anoth
applic
rapid
cultur
assay
gleav
et
al
ziegler
et
al
techniqu
adapt
rapid
diagnosi
infect
caus
respiratori
virus
wari
et
al
ziegler
et
al
recent
describ
rapid
cultur
assay
allow
typeand
subtypespecif
identif
influenza
virus
directli
clinic
specimen
overnight
incub
mdck
cultur
ziegler
et
al
although
rapid
cultur
assay
yield
isol
analysi
posit
specimen
reinocul
standard
cultur
without
consider
loss
infect
result
rapid
cultur
known
altern
cultur
supernat
store
use
reinocul
detect
virus
nasopharyng
aspir
patient
acut
respiratori
diseas
ifa
develop
use
rabbit
antisera
antispeci
conjug
method
breakthrough
rapid
diagnosi
respiratori
virus
excel
result
obtain
nasal
aspir
collect
specif
train
person
exfoli
epitheli
cell
care
wash
mucu
nonspecif
stain
materi
specimen
read
done
experienc
microscopist
later
technolog
improv
prepar
immunoreag
monoclon
antibodi
nonspecif
fluoresc
reduc
intens
specif
fluoresc
increas
kim
et
al
reagent
commerci
avail
hierholz
collect
nasopharyng
specimen
requir
expertis
ifa
transport
specimen
requir
special
attent
specimen
kept
cold
time
cell
separ
fix
microscop
slide
ifa
technolog
particularli
use
small
hospit
laboratori
transport
specimen
quick
number
specimen
test
daili
limit
experienc
reader
alway
avail
later
sensit
immunoassay
ria
trfia
test
develop
detect
respiratori
virus
arstila
halonen
grandien
et
al
halonen
et
al
halonen
et
al
halonen
et
al
assay
addit
advantag
specimen
transport
critic
sinc
intact
cell
requir
treatment
specimen
practic
bulk
test
specimen
possibl
read
print
test
result
object
read
immunofluoresc
howev
final
interpret
test
result
often
requir
expertis
mclntosh
et
al
trfia
biotineia
base
monoclon
antibodi
oneincub
principl
develop
sensit
consider
improv
time
test
becam
practic
fewer
incub
wash
step
halonen
et
al
wall
et
al
hierholz
et
al
scalia
et
al
format
trfia
eucniidelubehod
moos
fig
principl
monoclon
onestep
timeresolv
fluoroimmunoassay
detect
influenza
viru
shown
fig
treat
specimen
ad
simultan
label
led
euchel
biotin
detector
monoclon
antibodi
well
polystyren
strip
previous
coat
optim
concentr
captur
monoclon
antibodi
incub
h
well
wash
enhanc
solut
trfia
peroxidas
label
avidin
biotineia
ad
test
format
antigen
specimen
detector
antibodi
react
quickli
efficientlyin
liquidphas
later
form
antigenantibodi
complex
bind
captur
antibodi
solid
phase
format
use
immunoreag
prepar
monoclon
antibodi
sensit
higher
convent
twostep
assay
antigen
first
bound
catch
antibodi
solid
phase
first
incub
wash
excess
antigen
nonbound
materi
detector
antibodi
ad
well
incub
sensit
ngml
antigen
obtain
monoclon
oneincub
trfia
hierholz
etal
arstila
halonen
monoclon
trfia
use
depart
virolog
univers
turku
daili
diagnosi
influenza
b
parainfluenza
rsv
adenovirus
groupreact
hexon
test
sinc
nasopharyng
aspir
test
epidemiolog
year
year
specimen
includ
thousand
posit
test
test
done
primarili
rapid
diagnosi
hospit
children
acut
respiratori
infect
result
also
use
mani
clinic
epidemiolog
studi
addit
seven
respiratori
virus
indic
monoclon
trfia
develop
parainfluenza
mumpsviru
hierholz
etal
enterovirus
respons
acut
hemorrhag
conjunct
hierholz
et
al
human
respiratori
coronavirus
hierholz
etal
aand
bgroup
rsv
strain
hierholz
et
al
wari
recent
eia
kit
allow
detect
rsv
influenza
viru
type
clinic
specimen
within
approxim
min
becom
commerci
avail
dominguez
et
al
krilov
etal
ryanpoiri
etal
test
suffici
sensit
perform
bedsid
physician
offic
weak
posit
result
howev
confirm
standard
method
viral
diagnosi
base
detect
viral
nucleic
acid
clinic
specimen
new
challeng
possibl
use
detect
respiratori
virus
howev
technolog
may
yet
reach
practic
reliabl
requir
first
detect
system
adenovirus
develop
hierholz
et
al
later
expand
experi
enterovirus
rhinovirus
halonen
etal
enterovirus
particularli
rhinovirus
interest
group
reliabl
antigen
test
groupreact
test
avail
diagnosi
flexibl
pcr
hybrid
make
possibl
design
test
wide
rang
specif
reagent
select
group
subgroup
type
even
strain
specif
develop
new
pcr
format
want
groupspecif
test
rhinovirus
anoth
test
enterovirus
addit
prefer
adapt
technolog
alreadi
use
diagnost
laboratori
much
possibl
use
microtit
strip
detect
pcr
product
liquidphas
hybrid
result
test
format
nearli
ident
use
onestep
antigen
assay
special
attent
paid
remov
nonspecif
inhibitor
pcr
clinic
specimen
neg
result
pcr
may
indic
inhibitor
correctli
remov
often
pcr
sensit
limit
number
viral
genom
requir
posit
result
sensit
may
decreas
sever
log
test
neg
even
presenc
larg
amount
viru
inhibitor
complet
remov
experi
liquidphas
hybrid
indic
primer
construct
produc
pcr
product
less
bp
long
longer
may
form
loop
prevent
hybrid
probe
optim
length
may
bp
probe
select
overlap
primer
region
mer
use
microtitr
strip
coat
streptavidin
biotinyl
probe
liquidphas
hybrid
assay
pcr
product
howev
streptavidin
coat
directli
polystyren
partial
activ
form
coat
strip
first
biotinyl
bovin
albumin
follow
streptavidin
dahlen
et
al
biotinyl
probe
tripleco
strip
store
refriger
month
use
commerci
reagent
ultraspec
cinnabiotecx
laboratori
inc
houston
texa
extract
rna
clinic
specimen
contain
guanidinium
isothiocyan
denatur
protein
includ
enzym
specimen
proteinas
k
requir
may
anoth
sourc
pcr
inhibitor
rna
precipit
extract
cold
isopropanol
precipit
purifi
wash
cold
ethanol
repeat
least
three
time
may
import
final
precipit
dri
dissolv
distil
water
min
otherwis
may
difficult
dissolv
precipit
rna
purifi
isopropanol
precipit
filtrat
wash
step
use
millipor
ultrafreemc
filter
unit
polysulfon
type
ptgc
membran
highli
protein
retent
porou
small
molecular
size
materi
nucleic
acid
resuspend
top
filter
format
hybrid
assay
shown
fig
singlestrand
pcr
product
boil
cool
exonucleasetr
ad
togeth
probe
label
euchel
biotinyl
probeco
well
incub
h
ambient
temperatur
wash
step
enhanc
solut
ad
fluoresc
measur
fluoromet
sensit
enteroviru
pcrhybrid
approxim
molecul
purifi
coxsacki
rna
compar
infect
use
two
echoviru
strain
higher
rhinovirusposit
specimen
found
pcr
hybrid
cultur
similar
find
report
group
howev
one
cultureposit
specimen
pcr
neg
enteroviru
pcr
cultur
posit
respiratori
specimen
posit
cultureneg
specimen
also
neg
pcr
adenoviru
pcr
slightli
respiratori
speci
men
posit
pcr
cultur
cultur
posit
pcr
neg
specimen
may
indic
remov
pcr
inhibitor
clinic
specimen
incomplet
eia
igg
antibodi
assay
pair
serum
specimen
effici
serodiagnost
method
respiratori
virus
vastli
superior
complement
fixat
test
wherea
igm
assay
less
sensit
comparison
koskinen
et
al
vuorinen
meurman
nohynek
et
al
igg
antibodi
avid
test
use
distinguish
primari
infect
reinfect
least
rsv
meurman
et
al
igg
antibodi
assay
often
complement
rapid
viral
diagnost
method
acut
phase
specimen
viru
isol
antigen
detect
pcr
alway
avail
addit
subclin
infect
diagnos
serolog
remain
use
evalu
new
diagnost
method
well
recombin
antigen
may
prove
valuabl
futur
respiratori
virus
harmon
et
al
fulli
equip
diagnost
laboratori
viru
cultur
andor
rapid
cultur
assay
front
line
diagnost
method
acut
respiratori
infect
simultan
antigen
detect
carri
whenev
rapid
diagnosi
requir
mani
virus
result
rapid
cultur
assay
avail
quickli
result
antigen
detect
assay
pcr
number
respiratori
specimen
sent
laboratori
larg
cultur
may
practic
select
specimen
laboratori
cell
cultur
avail
result
highli
sensit
antigen
assay
almost
ident
cultur
wari
et
al
standard
isol
rapid
cultur
assay
advantag
cultur
viru
avail
analysi
requir
eg
drugsuscept
test
sequenc
analysi
although
total
diagnost
positivityr
almost
ident
method
may
specimen
posit
one
anoth
question
method
use
antigen
detect
discuss
earlier
depend
laboratori
locat
number
specimen
test
previou
experi
laboratori
expertis
avail
also
avail
wellcharacter
immunoreag
import
overal
result
ifa
use
monoclon
antibodi
immunoreag
experienc
reader
modern
uv
microscop
almost
ident
highli
sensit
solidphas
immunoassay
futur
role
pcr
depend
new
develop
promis
technolog
need
effici
simpl
method
extract
purif
dna
rna
simpl
test
specif
identif
pcr
product
prefer
practic
dna
amplif
techniqu
isotherm
amplif
walker
et
al
new
extract
purif
method
develop
need
intern
control
check
remov
inhibitor
individu
specimen
otherwis
neg
result
may
correct
also
need
improv
method
control
crosscontamin
requir
addit
minim
possibl
contamin
specimen
time
specimen
collect
handl
ie
even
reach
laboratori
contamin
problem
difficult
avoid
assay
sensit
level
one
dna
rna
molecul
problem
might
overcom
lower
sensit
pcr
like
less
sensit
pcr
system
still
would
pick
isolationposit
specimen
natur
target
pcr
diagnosi
respiratori
infect
difficulti
cultur
identif
coronavirus
broad
test
group
react
rhinoviru
enteroviru
test
also
exampl
futur
respiratori
viru
pcr
econom
aspect
respiratori
viru
diagnosi
kept
mind
one
ultim
goal
laboratori
diagnosi
uncompl
upper
respiratori
infect
reduc
number
unnecessari
prescript
antibiot
mean
laboratori
diagnosi
infect
expens
cours
antibiot
treatment
date
unfortun
diagnost
techniqu
meet
criteria
rel
sensit
method
latex
agglutin
test
selfcontain
eia
kit
becom
avail
may
futur
offer
widespread
costeffect
use
viru
diagnost
servic
hospit
physician
offic
